<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02871531</url>
  </required_header>
  <id_info>
    <org_study_id>Extended criteria pneumaticPPV</org_study_id>
    <nct_id>NCT02871531</nct_id>
  </id_info>
  <brief_title>Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment in Patients With Extended Criteria</brief_title>
  <official_title>A Randomized Controlled Trial Comparing Pneumatic Retinopexy Versus Vitrectomy for the Management of Primary Retinal Detachment in Patients With Extended Criteria; Anatomical Success, Functional Success and Impact on Patient Quality of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unity Health Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unity Health Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To compare outcomes of retinal detachment repair following pneumatic retinopexy&#xD;
      (PnR) versus pars plana vitrectomy in terms of anatomical success, functional success and&#xD;
      patient quality of life in patients with extended criteria.&#xD;
&#xD;
      Methods: A prospective, randomized, controlled trial will be conducted with 178 patients&#xD;
      presenting at St. Michael's Hospital with primary retinal detachment (RD). Inclusion criteria&#xD;
      include: a single or multiple retinal tears in detached retina between 7 and 5 o'clock being&#xD;
      of any size and any distance apart from each other, including giant retinal tears with&#xD;
      inferior aspect above 5 and 7 o'clock, RD with no identifiable tear but where suspected tear&#xD;
      is between 7 and 5 o'clock, retinoschisis with RD if tears are located between 7 and 5&#xD;
      o'clock, mild proliferative vitreoretinopathy, none or mild vitreous hemorrhage. Patients&#xD;
      will be excluded if there is a small retinal tear or multiple tears less than 30o apart&#xD;
      between 8 and 4 o'clock in detached retina, retinal tear in detached retina between 5 and 7&#xD;
      o'clock, &lt;18 years old, inability to read English, mental incapacity, previous history of RD,&#xD;
      scleral buckle or vitrectomy in index eye, inability to maintain appropriate head posture at&#xD;
      post-operative period and inability to visualize peripheral retinal due to media opacity.&#xD;
      Patients will be randomly allocated into two groups: PnR + cryotherapy/laser or vitrectomy +&#xD;
      cryotherapy/laser and the intervention will take place within 24 hours and 72 hours for&#xD;
      attached and detached macula status, respectively. Patients will undergo a complete&#xD;
      ophthalmological examination, including visual acuity and fundus assessment at baseline and&#xD;
      at 3, 6 and 12 months after surgery. Visual acuity will also be measured at 1, 7 and 30 days&#xD;
      after surgery. Global health related quality of life will be evaluated with the SF-36v2&#xD;
      questionnaire at baseline, 1 month, 1 and 2 years after intervention, while the VFG25&#xD;
      questionnaire will be applied at 3, 6, 12 and 24 months after surgery to measure vision&#xD;
      related quality of life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity (ETDRS)</measure>
    <time_frame>12 months post intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual acuity (ETDRS)</measure>
    <time_frame>3, 6 and 24 months post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity (Snellen)</measure>
    <time_frame>1 week, 1, 3, 6, 12 and 24 months post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective visual function (VFQ25)</measure>
    <time_frame>3, 6, 12 and 24 months post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anatomical success (complete retinal re-attachment with no adjuvant surgical procedure)</measure>
    <time_frame>3, 6, 12 and 24 months post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective health related quality of life (SF-36v2)</measure>
    <time_frame>baseline, 1 month, 12 and 24 months post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aniseikonia rates</measure>
    <time_frame>12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metamorphopsia rates</measure>
    <time_frame>3, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal displacement rate measured with fundus autofluorescence</measure>
    <time_frame>3 and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">178</enrollment>
  <condition>Rhegmatogenous Retinal Detachment</condition>
  <arm_group>
    <arm_group_label>Pneumatic retinopexy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with retinal detachment allocated to pneumatic retinopexy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with retinal detachment allocated to vitrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pneumatic retinopexy</intervention_name>
    <arm_group_label>Pneumatic retinopexy</arm_group_label>
    <other_name>Pneumatic retinopexy plus laser/cryotherapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vitrectomy</intervention_name>
    <arm_group_label>Vitrectomy</arm_group_label>
    <other_name>Pars plana vitrectomy plus laser/cryotherapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Single retinal tear or group of tears (any distance apart) in detached retina located&#xD;
             between 7 and 5 o'clock.&#xD;
&#xD;
          -  Retinal detachment with no identifiable tear but where suspected tear is located&#xD;
             between 7-5 o'clock based on Lincoff rules&#xD;
&#xD;
          -  Any size of retinal tear, including giant retinal tears, if the inferior aspect of it&#xD;
             is above 5 and 7 o'clock&#xD;
&#xD;
          -  Retinoschisis with retinal detachment if tears are located between 7 and 5 o'clock&#xD;
&#xD;
          -  There may be mild proliferative vitreoretinopathy (unless there is a visible traction&#xD;
             on the break)&#xD;
&#xD;
          -  None or mild vitreous hemorrhage. Note: vitreous hemorrhage will be considered mild if&#xD;
             it does not impair an adequate examination of the retinal periphery.&#xD;
&#xD;
          -  In the opinion of the investigator, PnR is likely to achieve anatomical re-attachment&#xD;
             of the retina&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Group of tears &lt;30o apart in detached retina if all located within 8-4 o'clock&#xD;
&#xD;
          -  Single retinal tear smaller than 1 o'clock in detached retina between 8-4 o'clock&#xD;
&#xD;
          -  Retinal tears below the 5 and 7 o'clock meridian in detached retina (note that&#xD;
             additional tears in attached retina are acceptable)&#xD;
&#xD;
          -  Inability to read English language&#xD;
&#xD;
          -  Age &lt;18 years&#xD;
&#xD;
          -  Mental incapacity&#xD;
&#xD;
          -  Previous vitrectomy or scleral buckle (index eye)&#xD;
&#xD;
          -  Previous retinal detachment (index eye)&#xD;
&#xD;
          -  Inability to maintain the strict post-operative posturing requirements of pneumatic&#xD;
             retinopexy&#xD;
&#xD;
          -  Inability to carry out detailed examination of the peripheral retina due to media&#xD;
             opacity NOTE: Lens/posterior hyaloid status does not affect eligibility.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rajeev Muni, FRSCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>staff</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Verena Juncal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>research fellow</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rajeev Muni, MD</last_name>
    <phone>416-867-7411</phone>
    <email>rajeev.muni@utoronto.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Veren Juncal, MD</last_name>
    <phone>416-867-7411</phone>
    <email>verenajuncal@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St. Michael's Hospital Eye Clinic</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C2T2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajeev Muni, MD Msc FRCSC</last_name>
      <phone>4168677411</phone>
    </contact>
    <contact_backup>
      <last_name>Phillip To</last_name>
      <phone>4168677411</phone>
      <email>top@smh.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Kertes</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 11, 2016</study_first_submitted>
  <study_first_submitted_qc>August 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2016</study_first_posted>
  <last_update_submitted>August 21, 2019</last_update_submitted>
  <last_update_submitted_qc>August 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>retinal detachment</keyword>
  <keyword>pneumatic retinopexy</keyword>
  <keyword>vitrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Detachment</mesh_term>
    <mesh_term>Dissociative Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

